Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q4	-- / 10.100B	--
--	2025/Q3	-- / 11.300B	--
Oct 30, 2024	2025/Q2	8.512B / 11.300B	--
Jul 30, 2024	2025/Q1	8.145B / 11.300B	--
May 10, 2024	2024/Q4	9.153B / 12.382B	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q4-- / 10.100B--

--2025/Q3-- / 11.300B--

Oct 30, 20242025/Q28.512B / 11.300B--

Jul 30, 20242025/Q18.145B / 11.300B--

May 10, 20242024/Q49.153B / 12.382B--

Unlock Free Earnings Estimates

Open Account

JCR Pharmaceuticals: Confirmation letter

Nov 13 21:16 ET

JCR Pharmaceuticals: Half Year Report - Term 50 (2024/04/01 - 2025/03/31)

Nov 13 21:15 ET

JCR Pharmaceuticals: Notice Concerning Dividends from Surplus Funds (Interim Dividend)

Oct 30 03:00 ET

JCR Pharmaceuticals: Financial results briefing materials for the 2nd quarter of the fiscal year ending March 31, 2025

Oct 30 03:00 ET

Symbol Price % Chg

See the daily top gainer.

Analysis

Updated: Nov 26, 2024

Buy

No Data